Cyrus Soli Poonawalla’s Serum Institute of India made the most of the country’s demand for vaccines. Though unlisted, Poonawalla tops the list, followed by Dilip Shanghvi & family of Sun Pharmaceuticals. The other two biggies are Bawri family of Macleods Pharmaceuticals and Hasmukh Chudgar of Intas Pharma.
Top Stories
Infographics
Covid catapults Cyrus Poonawalla to richest in pharma
Cyrus Soli Poonawalla’s Serum Institute of India made the most of the country’s demand for vaccines.
Infographics
When Interest Rates Head North…
Pricier overseas borrowing, higher bank loan rates and large issuances triggered the demand for corporate bonds.
Expenditure on Central schemes up 20% in FY24
India's expenditure on Central schemes in FY23 rose from budgeted ₹16.2 lakh crore to ₹18.6 lakh crore.
Retail, NBFCs drive credit offtake in FY23
India's gross bank credit off-take rose 15% in FY23 to ₹136.8 lakh crore. The growth was led by sectors such as NBFCs, personal loan and services segments.
The Start-up Boom
The Indian start-up ecosystem is now the third-largest in the world, thanks to the rise of digital technologies and growth in the number of young entrepreneurs.
Infographics
When Interest Rates Head North…
Pricier overseas borrowing, higher bank loan rates and large issuances triggered the demand for corporate bonds.
Expenditure on Central schemes up 20% in FY24
India's expenditure on Central schemes in FY23 rose from budgeted ₹16.2 lakh crore to ₹18.6 lakh crore.
Retail, NBFCs drive credit offtake in FY23
India's gross bank credit off-take rose 15% in FY23 to ₹136.8 lakh crore. The growth was led by sectors such as NBFCs, personal loan and services segments.
The Start-up Boom
The Indian start-up ecosystem is now the third-largest in the world, thanks to the rise of digital technologies and growth in the number of young entrepreneurs.
Leave a Comment
Your email address will not be published. Required field are marked*